83 related articles for article (PubMed ID: 21873169)
1. Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosis.
Yoshida T; Kinugasa T; Akagi Y; Kawahara A; Romeo K; Shiratsuchi I; Ryu Y; Gotanda Y; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2517-25. PubMed ID: 21873169
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
5. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
[TBL] [Abstract][Full Text] [Related]
7. [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum].
Young Tabusso F; Payet Meza E; Celis Zapata J; Ruiz Figueroa E; Berrospi Espinoza F
Rev Gastroenterol Peru; 2002; 22(3):213-20. PubMed ID: 12378215
[TBL] [Abstract][Full Text] [Related]
8. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
[TBL] [Abstract][Full Text] [Related]
9. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma].
Jiang SM; Wang RB; Yu JM; Zhu KL; Mu DB; Xu ZF
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):602-5. PubMed ID: 19102938
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer].
He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM
Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220
[TBL] [Abstract][Full Text] [Related]
13. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer].
Zhou YJ; Wan FL; Yao LH; Feng LY
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):167-71. PubMed ID: 18344087
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
18. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
19. [Multivariate Cox analysis on prognostic factors after surgery for rectal carcinoma].
Liang H; Hao XS; Wang P; Wang XN; Li JW; Wang JC; Wang DC
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):688-91. PubMed ID: 15777510
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing outcome of surgery for stage I rectal cancer.
Celen O; Yildirim E; Berberoglu U
Neoplasma; 2004; 51(6):487-90. PubMed ID: 15640960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
